Koyfin Home > Directory > Health Care > Kindred Biosciences

Kindred Biosciences Price Chart KIN

Historical daily share price chart and data for Kindred Biosciences since 2013 adjusted for splits and dividends. The latest closing price for Kindred Biosciences as of October 21, 2020 is $4.03.
  • In 2020 the stock opened at $8.55 and closed at $4.03 for a loss of -112% YTD.
  • In 2019 the stock opened at $10.86 and closed at $8.48 for a loss of -28%.
  • In 2018 the stock opened at $9.45 and closed at $10.95 for a gain of 14%.
  • In 2017 the stock opened at $4.50 and closed at $9.45 for a gain of 52%.
View Chart On Koyfin

Kindred Biosciences Summary

Stock Symbol: KIN

Kindred Biosciences Company Info

Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.
Market Cap
163m
Dividend Yield
0 %
Beta vs SPX
1.26
Short Interest
58.7 %
30D Volatility
51.47
Hedge Fund Held
0 %
Competitors

Last 10 Days of KIN Prices

10/21/2020$4.03
10/20/2020$4.14
10/19/2020$4.15
10/16/2020$4.29
10/15/2020$4.30
10/14/2020$4.38
10/13/2020$4.65
10/12/2020$4.80
10/09/2020$4.85
10/08/2020$4.95